- Home
- SYPR vs CASI Comparison
SYPR vs CASI Comparison
Compare SYPR & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYPR
- CASI
- Stock Information
- Founded
- SYPR 1997
- CASI 1991
- Country
- SYPR United States
- CASI China
- Employees
- SYPR N/A
- CASI N/A
- Industry
- SYPR Industrial Machinery/Components
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- SYPR Industrials
- CASI Health Care
- Exchange
- SYPR Nasdaq
- CASI Nasdaq
- Market Cap
- SYPR 37.1M
- CASI 33.4M
- IPO Year
- SYPR 1994
- CASI 1996
- Fundamental
- Price
- SYPR $1.61
- CASI $2.15
- Analyst Decision
- SYPR
- CASI Strong Buy
- Analyst Count
- SYPR 0
- CASI 1
- Target Price
- SYPR N/A
- CASI $6.00
- AVG Volume (30 Days)
- SYPR 15.2K
- CASI 8.5K
- Earning Date
- SYPR 03-27-2025
- CASI 05-13-2025
- Dividend Yield
- SYPR N/A
- CASI N/A
- EPS Growth
- SYPR N/A
- CASI N/A
- EPS
- SYPR N/A
- CASI N/A
- Revenue
- SYPR $140,180,000.00
- CASI $22,055,000.00
- Revenue This Year
- SYPR N/A
- CASI N/A
- Revenue Next Year
- SYPR N/A
- CASI $134.79
- P/E Ratio
- SYPR N/A
- CASI N/A
- Revenue Growth
- SYPR 2.90
- CASI N/A
- 52 Week Low
- SYPR $1.27
- CASI $2.04
- 52 Week High
- SYPR $3.72
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- SYPR 43.16
- CASI 42.82
- Support Level
- SYPR $1.55
- CASI $2.10
- Resistance Level
- SYPR $1.80
- CASI $2.52
- Average True Range (ATR)
- SYPR 0.09
- CASI 0.22
- MACD
- SYPR 0.02
- CASI 0.00
- Stochastic Oscillator
- SYPR 50.00
- CASI 14.58
About SYPR Sypris Solutions Inc.
Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sale of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.